Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.

MLA

Frat, Jean-Pierre, et al. “Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.” JAMA: Journal of the American Medical Association, vol. 328, no. 12, Sept. 2022, pp. 1212–22. EBSCOhost, https://doi.org/10.1001/jama.2022.15613.

APA

Frat, J.-P., Quenot, J.-P., Badie, J., Coudroy, R., Guitton, C., Ehrmann, S., Gacouin, A., Merdji, H., Auchabie, J., Daubin, C., Dureau, A.-F., Thibault, L., Sedillot, N., Rigaud, J.-P., Demoule, A., Fatah, A., Terzi, N., Simonin, M., Danjou, W., & Carteaux, G. (2022). Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 328(12), 1212–1222. https://doi.org/10.1001/jama.2022.15613

Chicago

Frat, Jean-Pierre, Jean-Pierre Quenot, Julio Badie, Rémi Coudroy, Christophe Guitton, Stephan Ehrmann, Arnaud Gacouin, et al. 2022. “Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.” JAMA: Journal of the American Medical Association 328 (12): 1212–22. doi:10.1001/jama.2022.15613.